INS and diabetes mellitus: In some studies of diabetes in humans, higher serum levels of FGF23 were seen in diabetes patients compared to healthy individuals.(26,27) Bär et al.(28) observed that serum FGF23 levels were significantly increased in mice with STZ-induced diabetes compared with control mice in a short experimental period of 10 days, and that these levels returned to control levels following insulin therapy.